MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-14-2023
Bellerophon Therapeutics EBITDA per Share 2011-2026 | BLPH
Annual EBITDA per Share Bellerophon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.34 | -2.12 | -3.37 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.12 | -3.37 | -2.61 |
Quarterly EBITDA per Share Bellerophon Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.18 | -0.43 | 0.14 | - | -0.54 | -0.69 | -0.59 | - | -0.51 | -0.55 | -0.62 | -0.86 | -0.87 | -0.76 | -0.89 | -0.94 | -1.01 | -0.93 | -1 | -1.22 | -1.78 | -2.06 | -2.23 | -0.13 | -0.18 | -0.19 | -0.15 | -0.36 | -0.3 | -0.39 | -0.54 | -0.83 | -0.87 | -0.9 | -1.27 | -1.62 | -1.96 | -2.15 | -1.84 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.14 | -2.23 | -0.87 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
-0.63 | $ 2.8 | -3.69 % | $ 158 M |  China |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
3.54 | $ 80.89 | -1.35 % | $ 1.56 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
23.9 | $ 341.41 | -0.45 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-0.39 | $ 2.68 | 3.88 % | $ 16.8 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.23 | -1.01 % | $ 7.77 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | USA |
 |
Aptose Biosciences
APTO
|
0.05 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | USA |
 |
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | USA |
 |
Biogen
BIIB
|
4.62 | $ 177.21 | 0.61 % | $ 25.8 B | USA |
 |
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-4.78 | $ 28.43 | -2.94 % | $ 2.34 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-8.25 | $ 224.26 | 0.14 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-2.6 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
62.6 | $ 115.04 | -1.49 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
1.11 | $ 9.65 | - | $ 1.52 B | Britain |
 |
Arrowhead Pharmaceuticals
ARWR
|
0.9 | $ 68.78 | -0.5 % | $ 9.2 B | USA |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
CASI Pharmaceuticals
CASI
|
-0.304 | $ 1.01 | 1.6 % | $ 137 M | USA |
 |
Catalyst Biosciences
CBIO
|
-1 | $ 9.79 | -3.55 % | $ 644 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.87 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.0 | -3.61 % | $ 8.7 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
1.01 | $ 14.0 | -0.78 % | $ 4.33 B | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Cerus Corporation
CERS
|
-0.07 | $ 2.28 | -1.94 % | $ 421 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | USA |
 |
Baudax Bio
BXRX
|
-171 | - | 0.59 % | $ 63 K | USA |